Affinity Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.24M | Sell |
8,898
-37
| -0.4% | -$7.96K | 1.14% | 24 |
|
|
2026
Q1 | $1.94M | Buy |
8,935
+6
| +0.1% | +$1.33K | 1.22% | 22 |
|
|
2025
Q4 | $2.04M | Sell |
8,929
-68
| -0.8% | -$15.5K | 1.36% | 18 |
|
|
2025
Q3 | $2.08M | Sell |
8,997
-154
| -2% | -$31.4K | 1.41% | 19 |
|
|
2025
Q2 | $1.7M | Sell |
9,151
-293
| -3% | -$54.5K | 1.29% | 21 |
|
|
2025
Q1 | $1.98M | Sell |
9,444
-802
| -8% | -$156K | 1.61% | 10 |
|
|
2024
Q4 | $1.82M | Sell |
10,246
-2,222
| -18% | -$409K | 1.52% | 15 |
|
|
2024
Q3 | $2.46M | Sell |
12,468
-240
| -2% | -$44.8K | 1.69% | 12 |
|
|
2024
Q2 | $2.18M | Hold |
12,708
| – | – | 1.64% | 14 |
|
|
2024
Q1 | $2.31M | Buy |
12,708
+1,582
| +14% | +$273K | 1.69% | 14 |
|
|
2023
Q4 | $1.72M | Sell |
11,126
-918
| -8% | -$134K | 1.17% | 21 |
|
|
2023
Q3 | $1.8M | Sell |
12,044
-344
| -3% | -$50.5K | 1.16% | 18 |
|
|
2023
Q2 | $1.67M | Sell |
12,388
-3,622
| -23% | -$531K | 0.97% | 28 |
|
|
2023
Q1 | $2.55M | Sell |
16,010
-5,189
| -24% | -$793K | 1.36% | 12 |
|
|
2022
Q4 | $3.43M | Sell |
21,199
-1,520
| -7% | -$233K | 1.58% | 9 |
|
|
2022
Q3 | $3.05M | Sell |
22,719
-536
| -2% | -$76.9K | 1.58% | 8 |
|
|
2022
Q2 | $3.56M | Sell |
23,255
-463
| -2% | -$70.7K | 1.74% | 6 |
|
|
2022
Q1 | $3.85M | Sell |
23,718
-2,928
| -11% | -$425K | 1.58% | 7 |
|
|
2021
Q4 | $3.61M | Sell |
26,646
-209
| -0.8% | -$24.7K | 1.45% | 8 |
|
|
2021
Q3 | $2.9M | Buy |
26,855
+36
| +0.1% | +$4.11K | 1.3% | 17 |
|
|
2021
Q2 | $3.02M | Sell |
26,819
-15,950
| -37% | -$1.8M | 1.36% | 20 |
|
|
2021
Q1 | $4.63M | Sell |
42,769
-323
| -0.7% | -$34.5K | 1.7% | 10 |
|
|
2020
Q4 | $4.62M | Buy |
43,092
+913
| +2% | +$87.7K | 1.86% | 7 |
|
|
2020
Q3 | $3.69M | Buy |
42,179
+3,260
| +8% | +$307K | 1.62% | 17 |
|
|
2020
Q2 | $3.82M | Sell |
38,919
-290
| -0.7% | -$25.5K | 1.82% | 13 |
|
|
2020
Q1 | $2.99M | Buy |
39,209
+13,538
| +53% | +$1.15M | 1.52% | 21 |
|
|
2019
Q4 | $2.27M | Buy |
25,671
+2,650
| +12% | +$220K | 0.82% | 47 |
|
|
2019
Q3 | $1.74M | Buy |
23,021
+4,202
| +22% | +$288K | 0.55% | 58 |
|
|
2019
Q2 | $1.37M | Buy |
18,819
+750
| +4% | +$59K | 0.39% | 62 |
|
|
2019
Q1 | $1.46M | Buy |
18,069
+249
| +1% | +$20.4K | 0.3% | 64 |
|
|
2018
Q4 | $1.64M | Sell |
17,820
-313
| -2% | -$27.5K | 0.29% | 64 |
|
|
2018
Q3 | $1.72M | Buy |
18,133
+9,773
| +117% | +$927K | 0.23% | 66 |
|
|
2018
Q2 | $775K | Sell |
8,360
-1,282
| -13% | -$125K | 0.11% | 103 |
|
|
2018
Q1 | $913K | Buy |
9,642
+454
| +5% | +$49.9K | 0.11% | 100 |
|
|
2017
Q4 | $889K | Buy |
9,188
+140
| +2% | +$13.2K | 0.1% | 100 |
|
|
2017
Q3 | $804K | Sell |
9,048
-20
| -0.2% | -$1.52K | 0.09% | 104 |
|
|
2017
Q2 | $658K | Buy |
+9,068
| New | +$610K | 0.08% | 107 |
|
|
2016
Q2 | – | Sell |
-307,219
| Closed | -$17.5M | – | 161 |
|
|
2016
Q1 | $17.5M | Buy |
307,219
+75,736
| +33% | +$4.22M | 1.54% | 21 |
|
|
2015
Q4 | $13.7M | Sell |
231,483
-480
| -0.2% | -$27.6K | 1.18% | 38 |
|
|
2015
Q3 | $12.6M | Buy |
231,963
+22,725
| +11% | +$1.48M | 1.15% | 40 |
|
|
2015
Q2 | $14.1M | Sell |
209,238
-8,644
| -4% | -$564K | 1.12% | 39 |
|
|
2015
Q1 | $12.8M | Buy |
217,882
+62,161
| +40% | +$3.76M | 0.92% | 49 |
|
|
2014
Q4 | $10.2M | Buy |
155,721
+8,131
| +6% | +$513K | 0.94% | 49 |
|
|
2014
Q3 | $8.53M | Buy |
+147,590
| New | +$8.19M | 0.86% | 53 |
|
Other funds holding ABBV
Affinity Investment Advisors's ABBV Position: Q2 2026 in Review
Affinity Investment Advisors reduced its AbbVie (ABBV) stake by 0.41% in Q2 2026, selling an estimated $7.96K and leaving 8,898 shares worth $2.24M. The position accounts for 1.14% of the portfolio, ranked #24.
Affinity Investment Advisors first reported a position in ABBV in Q3 2014 and has held it in 44 quarters since. The position peaked at $17.5M in Q1 2016. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Affinity Investment Advisors held 8,898 shares of AbbVie worth $2.24M as of Q2 2026.
- Affinity Investment Advisors sold 37 AbbVie shares in Q2 2026, an estimated $7.96K.
- AbbVie made up 1.14% of Affinity Investment Advisors's portfolio in Q2 2026, its #24 holding.
- Affinity Investment Advisors first reported a position in AbbVie in Q3 2014 and has held it in 44 quarters since.
- Affinity Investment Advisors's AbbVie position peaked at $17.5M in Q1 2016.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Affinity Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.